SARS and MERS: recent insights into emerging coronaviruses

de Wit, Emmie, van Doremalen, Neeltje, Falzarano, Darryl, Munster, Vincent J.·2016·Nature Reviews Microbiology
DOI 10.1038/nrmicro.2016.81

Cited by (1,002)

Items 301–400 of 1,002

  1. High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
    Yao Zhao, Xiaoyu Du, Yinkai Duan, Xiaoyan Pan, Yifang Sun, Tian You, Lin Han, Zhenming Jin, Weijuan Shang, Jing Yu et al. · 2021 · Protein & Cell
  2. Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review
    Nicholas E. Ingraham, Abdo Barakat, Ronald A. Reilkoff, Tamara L Bezdicek, Timothy W. Schacker, Jeffrey G. Chipman, Christopher James Tignanelli, Michael A. Puskarich · 2020 · European Respiratory Journal
  3. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
    Seri Jo, Suwon Kim, Dae Yong Kim, Mi Sun Kim, Dong Hae Shin · 2020 · Journal of Enzyme Inhibition and Medicinal Chemistry
  4. Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou
    Su-fen Zhang, Jiuling Tuo, Xubin Huang, Xun Zhu, Dingmei Zhang, Kai Zhou, Lei Yuan, Hong-jiao Luo, Bo-Jian Zheng, Kwok‐Yung Yuen et al. · 2018 · PLoS ONE
  5. Novel insights on the pulmonary vascular consequences of COVID-19
    François Potus, Vicky Mai, Marius Lebret, Simon Malenfant, Émilie Breton-Gagnon, Annie Christine Lajoie, Olivier Boucherat, Sébastien Bonnet, Steeve Provencher · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  6. Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants
    Isabella Alvim Guedes, Leon S. C. Costa, Karina B. Santos, Ana L. M. Karl, Gregório Kappaun Rocha, Iury M. Teixeira, Marcelo Monteiro Galheigo, Vívian Medeiros, Eduardo Krempser, Fábio Lima Custódio et al. · 2021 · Scientific Reports
  7. Inactivation of three emerging viruses – severe acute respiratory syndrome coronavirus, Crimean–Congo haemorrhagic fever virus and Nipah virus – in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light
    Markus Eickmann, Ute Gravemann, Wiebke Handke, Frank Tolksdorf, Stefan Reichenberg, Thomas H. Müller, Axel W. Seltsam · 2020 · Vox Sanguinis
  8. The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the Nidovirales order
    Zhi-Jian Zhou, Ye Qiu, Xing-Yi Ge · 2021 · Animal Diseases
  9. Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L
    Fei Yu, Ting Shuang Pan, Feng Huang, Ruosu Ying, Jun Liu, Huimin Fan, Junsong Zhang, Weiwei Liu, Yingtong Lin, Yaochang Yuan et al. · 2022 · Frontiers in Microbiology
  10. Analysis of the Infection Status of Healthcare Workers in Wuhan During the COVID-19 Outbreak: A Cross-sectional Study
    Lichun Zheng, Xiang Wang, Chongchong Zhou, Qin Liu, Shuang Li, Qin Sun, Mengjia Wang, Qian Zhou, Wenmei Wang · 2020 · Clinical Infectious Diseases
  11. Current and Perspective Diagnostic Techniques for COVID-19
    Xi Yuan, Chengming Yang, Qian He, Jun‐Hu Chen, Dongmei Yu, Jie Li, Shiyao Zhai, Zhifeng Qin, Ke Du, Zhenhai Chu et al. · 2020 · ACS Infectious Diseases
  12. Potential use of polyphenols in the battle against COVID-19
    Ines L. Paraiso, Johana S. Revel, Jan Frederik Stevens · 2020 · Current Opinion in Food Science
  13. The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis
    Amare Teshome, Aynishet Adane, Biruk Girma, Zeleke Abebaw Mekonnen · 2021 · Frontiers in Public Health
  14. Cardiovascular complications of COVID-19
    Farnaz Farshidfar, Navid Koleini, Hossein Ardehali · 2021 · JCI Insight
  15. Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detection
    Masateru Taniguchi, Shohei Minami, Chikako Ono, Rina Hamajima, Ayumi Morimura, Shigeto Hamaguchi, Yukihiro Akeda, Yuta Kanai, Takeshi Kobayashi, Wataru Kamitani et al. · 2021 · Nature Communications
  16. Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atom Simulations
    Angelo Spinello, Andrea Saltalamacchia, Alessandra Magistrato · 2020 · The Journal of Physical Chemistry Letters
  17. Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design
    Wioletta Rut, Zongyang Lv, Mikolaj Zmudzinski, Stephanie Patchett, Digant Nayak, Scott J. Snipas, Farid El Oualid, Tony T. Huang, Miklos Bekes, Marcin Drąg et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Detection of Emerging Zoonotic Pathogens: An Integrated One Health Approach
    Brian H. Bird, Jonna A. K. Mazet · 2017 · Annual Review of Animal Biosciences
  19. COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 ( DPP4 ) in disease severity?
    Margaret F. Bassendine, Simon H. Bridge, Geoffrey William McCaughan, Mark D. Gorrell · 2020 · Journal of Diabetes
  20. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication
    Yuchen Zhang, Rui Guo, Sharon H. Kim, Hardik Shah, Shuting Zhang, Jin Hua Liang, Yīng Fāng, Matteo Gentili, Colin N. O'Leary, Steve J. Elledge et al. · 2021 · Nature Communications
  21. Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review
    Sabeena Muhammed Mustafa, Hanan H. Balkhy, Musa Nur Gabere · 2017 · Journal of Infection and Public Health
  22. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19
    Hongyan Hou, Baole Zhang, Haishan Huang, Ying Luo, Sanlan Wu, G Tang, Wenyu Liu, L Mao, L Mao, Fei Wang et al. · 2020 · Clinical & Experimental Immunology
  23. New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
    Gangqiang Guo, Lele Ye, Kan Pan, Yu Zheng Chen, Dong Xing, Kejing Yan, Zhiyuan Chen, Ning Ding, Wenshu Li, Hong Huang et al. · 2020 · Frontiers in Cell and Developmental Biology
  24. Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran
    Nasser Malekpour Alamdari, Siamak Afaghi, Fatemeh Sadat Rahimi, Farzad Esmaeili Tarki, Sasan Tavana, Alireza Zali, Mohammad Fathi, Sara Besharat, Leyla Bagheri, Fatemeh Pourmotahari et al. · 2020 · The Tohoku Journal of Experimental Medicine
  25. Covid-19: Perspectives on Innate Immune Evasion
    Nima Taefehshokr, Sina Taefehshokr, Nima Hemmat, Bryan Heit · 2020 · Frontiers in Immunology
  26. The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)
    Peré Domingo, Isabel Mur, Virginia Pomar, Hèctor Corominas, Jordi Casademont, Natividad Benito · 2020 · EBioMedicine
  27. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome
    Chengjin Ye, Kevin Chiem, Jun‐Gyu Park, Fatai S. Oladunni, Roy N. Platt, Tim Anderson, Fernando Almazán, Juan Carlos de la Torre, Luis Martínez‐Sobrido · 2020 · mBio
  28. Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro
    Haixia Su, Sheng Yao, Wenfeng Zhao, Minjun Li, Jia Liu, Weijuan Shang, Hang Xie, Chang‐Qiang Ke, Mei-na Gao, Kunqian Yu et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Human Coronavirus in Hospitalized Children With Respiratory Tract Infections: A 9-Year Population-Based Study From Norway
    Inger Heimdal, Nina Moe, Sidsel Krokstad, Andreas Christensen, Lars Høsøien Skanke, Svein Arne Nordbø, Henrik Døllner · 2018 · The Journal of Infectious Diseases
  30. ENT manifestation in COVID-19 patients
    Mohammad Waheed El‐Anwar, Saad Elzayat, Yasser Ahmed Fouad · 2020 · Auris Nasus Larynx
  31. The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals
    Stephanie Evans, Emily Agnew, Emilia Vynnycky, James A. Stimson, Alex Bhattacharya, Christopher Michael Rooney, Ben Warne, Julie V. Robotham · 2021 · Philosophical Transactions of the Royal Society B Biological Sciences
  32. The RNA sensor MDA5 detects SARS-CoV-2 infection
    Natália G. Sampaio, Lise Chauveau, Jonny Hertzog, Anne Bridgeman, Gerissa Fowler, Jurgen P. Moonen, Maeva Dupont, Rebecca A Russell, Marko Noerenberg, Jan Rehwinkel · 2021 · Scientific Reports
  33. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
    Yi-Zhou Jiang, Limor Rubin, Tangming Peng, Linlin Liu, Xingan Xing, Philip Lazarovici, Wenhua Zheng · 2021 · International Journal of Biological Sciences
  34. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
    Ren‐Jun Hsu, Wei-Chieh Yu, Guan-Ru Peng, Chih-Hung Ye, SuiYun Hu, Patrick Chun Theng Chong, Kah Yi Yap, Jamie Yu Chieh Lee, Weichen Lin, Shu‐Han Yu · 2022 · Frontiers in Immunology
  35. Coronavirus Endoribonuclease Activity in Porcine Epidemic Diarrhea Virus Suppresses Type I and Type III Interferon Responses
    Xufang Deng, Albert Van Geelen, Alexandra Buckley, Amornrat O’Brien, Angela E. Pillatzki, Kelly Milton Lager, Kay S. Faaberg, Susan C. Baker · 2019 · Journal of Virology
  36. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Emergence, history, basic and clinical aspects
    Ahmed Ali Al-Qahtani · 2020 · Saudi Journal of Biological Sciences
  37. Does Partisanship Shape Investor Beliefs? Evidence from the COVID-19 Pandemic
    J. Anthony Cookson, Joseph E Engelberg, William Mullins · 2020 · The Review of Asset Pricing Studies
  38. The Potential Intermediate Hosts for SARS-CoV-2
    Jie Zhao, Wei Cui, Baoping Tian · 2020 · Frontiers in Microbiology
  39. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication
    Junjun Chu, Changsheng Xing, Yang Du, Tianhao Duan, Siyao Liu, Pengfei Zhang, Chumeng Cheng, Jill E. Henley, Xin Liu, Qian Chen et al. · 2021 · Nature Metabolism
  40. SARS‐CoV ‐2: At the Crossroad Between Aging and Neurodegeneration
    Alice Lippi, Renato Domingues, Cristian Setz, Tiago F. Outeiro, Anita Kriško · 2020 · Movement Disorders
  41. Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management
    Mengyuan Liu, Ting Wang, Yun Zhou, Yutong Zhao, Yan Zhang, Jianping Li · 2020 · Journal of Translational Internal Medicine
  42. Jumping species—a mechanism for coronavirus persistence and survival
    Vineet D. Menachery, Rachel L. Graham, Ralph Steven Baric · 2017 · Current Opinion in Virology
  43. Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study
    Jong Min Lee, Sung‐Soo Park, Tong Yoon Kim, Dong‐Gun Lee, Dong‐Wook Kim · 2021 · Cancers
  44. Multi-level inhibition of coronavirus replication by chemical ER stress
    Mohammed Samer Shaban, Christin Müller, Christin Mayr‐Buro, Hendrik Weiser, Johanna Meier‐Soelch, Benadict Vincent Albert, Axel Weber, Uwe Linne, Torsten Hain, Ilya Babayev et al. · 2021 · Nature Communications
  45. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice
    Jesus A. Silvas, Desarey Morales Vasquez, Jun‐Gyu Park, Kevin Chiem, Anna Allué‐Guardia, Andreu Garcia‐Vilanova, Roy N. Platt, Lisa Miorin, Thomas Kehrer, Anastasija Čupić et al. · 2021 · Journal of Virology
  46. COVID-19 Pandemic: A New Chapter in the History of Infectious Diseases
    Abdullah Balkhair · 2020 · Oman Medical Journal
  47. Viral-Induced Enhanced Disease Illness
    Maria K. Smatti, Asmaa A. Al Thani, Hadi Mohamad Yassine · 2018 · Frontiers in Microbiology
  48. COVID-19: Unanswered questions on immune response and pathogenesis
    Enrico Maggi, Giorgio Walter Canonica, Lorenzo Moretta · 2020 · Journal of Allergy and Clinical Immunology
  49. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment
    Sanket Shah, Debashish Danda, Chengappa G. Kavadichanda, Saibal Das, M. B. Adarsh, Vir Singh Negi · 2020 · Rheumatology International
  50. Artificial Intelligence‐Based Data‐Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine
    Ashwani Sharma, Tarun Virmani, Vipluv Pathak, Anjali Sharma, Kamla Pathak, Girish Kumar, Devender Pathak · 2022 · BioMed Research International
  51. Application of Chinese Medicine in Acute and Critical Medical Conditions
    Yun Luo, Chong‐Zhi Wang, Julia Hesse-Fong, Jaung‐Geng Lin, Chun‐Su Yuan · 2019 · The American Journal of Chinese Medicine
  52. On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges
    Vishnu Sankar Sivasankarapillai, Akhilash Mohanan Pillai, Abbas Rahdar, Parayil Sobha Anumol, Sabya Sachi Das, Athanasios C. Mitrοpoulos, Mahboobeh Heidari Mokarrar, George Z. Kyzas · 2020 · Nanomaterials
  53. Coronavirus Disease 2019 (COVID-19): Patogenesis, Manifestasi Klinis dan Pilihan Terapi
    Yelvi Levani, Aldo Dwi Prastya, Siska Mawaddatunnadila · 2021 · Jurnal Kedokteran dan Kesehatan
  54. Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis
    Ting Wu, Zhihong Zuo, Shuntong Kang, Liping Jiang, Xuan Luo, Zanxian Xia, Jing Liu, Xiaojuan Xiao, Mao Ye, Meichun Deng · 2020 · Aging and Disease
  55. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways
    Manon Laporte, Valerie Raeymaekers, Ria Van Berwaer, Julie Vandeput, Isabel Marchand-Casas, Hendrik Jan Thibaut, Dominique Van Looveren, Katleen Martens, Markus Hoffmann, Piet Maes et al. · 2021 · PLoS Pathogens
  56. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
    Balasubramanian Ganesh, Thangarasu Rajakumar, Malathi Mathiyazhakan, Manikandan Natesan, Nagaraj Jaganathasamy, Santhakumar Aridoss, Elangovan Arumugam, Yashpal Singh Malik · 2021 · Clinical Epidemiology and Global Health
  57. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection
    Hossein Khorramdelazad, Mohammad Hossein Kazemi, Alireza Najafi, Maryam Keykhaee, Reza Zolfaghari Emameh, Reza Falak · 2020 · Microbial Pathogenesis
  58. Autophagy in health and disease: From molecular mechanisms to therapeutic target
    Guang Xiu Lu, Yu Wang, Yin Pu Shi, Zhe Zhang, Canhua Huang, Weifeng He, Chuang Wang, Han‐Ming Shen · 2022 · MedComm
  59. Coronavirus disease 2019 and cardiovascular system: A narrative review
    Felix Kwenandar, Karunia Valeriani Japar, Vika Damay, Timotius Ivan Hariyanto, Michael S. Tanaka, Nata Pratama Hardjo Lugito, Andree Kurniawan · 2020 · IJC Heart & Vasculature
  60. The flexibility of ACE2 in the context of SARS-CoV-2 infection
    Emilia Pecora de Barros, Lorenzo Casalino, Zied Gaieb, Abigail C. Dommer, Yuzhang Wang, Lucy Fallon, Lauren E. Raguette, Kellon A. A. Belfon, Carlos L. Simmerling, Rommie E. Amaro · 2020 · Biophysical Journal
  61. Short-term predictions and prevention strategies for COVID-19: A model-based study
    Sk Shahid Nadim, Indrajit Ghosh, Joydev Chattopadhyay · 2021 · Applied Mathematics and Computation
  62. COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
    Abdur Rauf, Tareq Abu‐Izneid, Ahmed Olatunde, Anees Ahmed Khalil, Fahad Abdulrahman Alhumaydhi, Tabussam Tufail, Mohammad Ali Shariati, Максим Борисович Ребезов, Zainab M. Almarhoon, Yahia N. Mabkhot et al. · 2020 · International Journal of Environmental Research and Public Health
  63. Silver Nanoparticles as Potential Antiviral Agents
    Zubair Ahmed Ratan, Fazla Rabbi Mashrur, Anisha Parsub Chhoan, Sadi Md. Shahriar, Mohammad Faisal Haidere, Nusrat Jahan Runa, Sung-Gyu Kim, Dae‐Hyuk Kweon, Hassan Hosseinzadeh, Jae Youl Cho · 2021 · Pharmaceutics
  64. Betacoronavirus Adaptation to Humans Involved Progressive Loss of Hemagglutinin-Esterase Lectin Activity
    Mark J. G. Bakkers, Yifei Lang, Louris J. Feitsma, Ruben J. G. Hulswit, Stefanie A.H. de Poot, Arno L. W. van Vliet, Irina Margine, Jolanda D.F. de Groot-Mijnes, Frank J. M. van Kuppeveld, Martijn A. Langereis et al. · 2017 · Cell Host & Microbe
  65. Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID‐19
    Chi Zhang, Zhao Wu, Jia‐Wen Li, Kangan Tan, Wanna Yang, Hong Zhao, Gui‐Qiang Wang · 2020 · Journal of Medical Virology
  66. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
    Narayanappa Amruta, Wesley H. Chastain, Meshi Paz, Rebecca J. Solch-Ottaiano, Isabel C. Murray-Brown, Jaime B. Befeler, Timothy E. Gressett, Michele T. Longo, Elizabeth B. Engler-Chiurazzi, Gregory Jaye Bix · 2021 · Cytokine & Growth Factor Reviews
  67. Epigenetic Landscape during Coronavirus Infection
    Alexandra Schäfer, Ralph Steven Baric · 2017 · Pathogens
  68. Anesthetic Management of Patients with COVID 19 Infections during Emergency Procedures
    Shuai Zhao, Ken Ling, Hong Yan, Liang Zhong, Xiaohong Peng, Shanglong Yao, Jiapeng Huang, Xiangdong Chen · 2020 · Journal of Cardiothoracic and Vascular Anesthesia
  69. COVID‐19 in pregnancy: Placental and neonatal involvement
    Erica C. Prochaska, Minyoung Jang, Irina D. Burd · 2020 · American Journal of Reproductive Immunology
  70. Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19
    Simona Pisanti, Joris Deelen, Anna Maria Gallina, Mariella Caputo, Marianna Citro, Mario Abate, Nicoletta Sacchi, Carmine Vecchione, Rosanna Martinelli · 2020 · Journal of Translational Medicine
  71. Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial
    Ilad Alavi Darazam, Shervin Shokouhi, Mohamad Amin Pourhoseingholi, Seyed Sina Naghibi Irvani, Majid Mokhtari, Minoosh Shabani, Mahdi Amirdosara, Parham Torabinavid, Maryam Golmohammadi, SayedPayam Hashemi et al. · 2021 · Scientific Reports
  72. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China
    Ying Huang, Rui Yang, Ying Xü, Ping Gong · 2020 · medRxiv
  73. Viral Pneumonia: Etiologies and Treatment
    Dima Dandachi, Maria C. Rodriguez‐Barradas · 2018 · Journal of Investigative Medicine
  74. Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19
    Santosh Kumar, Kaining Zhi, Ahona Mukherji, Kelli A. Gerth · 2020 · Viruses
  75. Inhibition of the SARS-CoV-2 3CLpro main protease by plant polyphenols
    Miha Bahun, Marko Jukič, Domen Oblak, Luka Kranjc, Gregor Bajc, Matej Butala, Krištof Bozovičar, Tomaž Bratkovič, Črtomir Podlipnik, Nataša Poklar Ulrih · 2021 · Food Chemistry
  76. Male Fertility and the COVID-19 Pandemic: Systematic Review of the Literature
    Mohammad Ali Khalili, Kristian Leisegang, Ahmad A. Majzoub, Renata Finelli, Manesh Kumar Panner Selvam, Ralf Henkel, Mojgan Moshrefi, Ashok Kumar Agarwal · 2020 · The World Journal of Men s Health
  77. Immunosuppressive Drugs and COVID-19: A Review
    Tessa S Schoot, Angèle P. M. Kerckhoffs, Luuk B. Hilbrands, Rob J. van Marum · 2020 · Frontiers in Pharmacology
  78. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS‐CoV‐2
    Jukun Song, Yamei Li, Xiaolin Huang, Zhi Hong Chen, Yongdi Li, Chong Liu, Chen Zhu, Xiaofeng Duan · 2020 · Journal of Medical Virology
  79. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
    Claudia A. Jette, Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Frauke Muecksch, Yu Erica Lee, Kathryn E. Huey‐Tubman, Fabian Schmidt, Théodora Hatziioannou, Paul D. Bieniasz, Michel C. Nussenzweig et al. · 2021 · Cell Reports
  80. Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element
    Anushka C. Galasiti Kankanamalage, Yunjeong Kim, Vishnu C. Damalanka, Athri D. Rathnayake, Anthony R. Fehr, Nurjahan Mehzabeen, K.P. Battaile, S. Lovell, Gerald Henry Lushington, Stanley M. Perlman et al. · 2018 · European Journal of Medicinal Chemistry
  81. The powerful immune system against powerful COVID-19: A hypothesis
    Farzad Taghizadeh‐Hesary, Hassan Akbari · 2020 · Medical Hypotheses
  82. SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences
    Melika Lotfi, Nima Rezaei · 2020 · Journal of Medical Virology
  83. Molecular biology of coronaviruses: current knowledge
    I Made Artika, Aghnianditya Kresno Dewantari, Ageng Wiyatno · 2020 · Heliyon
  84. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
    Chengyuan Liang, Lei Tian, Yuzhi Liu, Nan Hui, Guaiping Qiao, Han Li, Zhenfeng Shi, Yonghong Tang, Dezhu Zhang, Xiaolin Xie et al. · 2020 · European Journal of Medicinal Chemistry
  85. Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review
    Stefania Caramaschi, Meghan Kapp, Sara Miller, Rosana Eisenberg, Joyce E. Johnson, Garretson Epperly, Antonino Maiorana, Guido Silvestri, Giovanna A. Giannico · 2021 · Modern Pathology
  86. Hypertension and Diabetes Delay the Viral Clearance in COVID-19 Patients
    Xiaoping Chen, Wenjia Hu, Jiaxin Ling, Pingzheng Mo, Yongxi Zhang, Qunqun Jiang, Zhiyong Ma, Qian Cao, Liping Deng, Shihui Song et al. · 2020 · medRxiv
  87. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients
    Xiaoqing Liu, Airu Zhu, Jiangping He, Zhao Chen, Lihui Lin, 徐远达, Feng Ye, Huijian Feng, Lin Luo, Baomei Cai et al. · 2020 · Protein & Cell
  88. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment
    Shawn D. Keil, Izabela K. Ragan, Susan Yonemura, Lindsay Hartson, Nicole K. Dart, Richard A. Bowen · 2020 · Vox Sanguinis
  89. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach
    Ishtiaque Ahammad, Samia Sultana Lira · 2020 · International Journal of Biological Macromolecules
  90. Excesso de mortalidade no Brasil em tempos de COVID-19
    Gulnar Azevedo e Silva, Beatriz Cordeiro Jardim, Cléber Vinícius Brito dos Santos · 2020 · Ciência & Saúde Coletiva
  91. The unique features of SARS‐CoV‐2 transmission: Comparison with SARS‐CoV, MERS‐CoV and 2009 H1N1 pandemic influenza virus
    Zhonglan Wu, David Harrich, Zhongyang Li, Dongsheng Hu, Dongsheng Li · 2020 · Reviews in Medical Virology
  92. In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
    Rongsong Ling, Yarong Dai, Boxuan Huang, Wenjie Huang, Jianfeng Yu, Xifeng Lu, Yi-Zhou Jiang · 2020 · Peptides
  93. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
    Ramy Mohamed Ghazy, Abdallah Mostafa Almaghraby, Ramy Shaaban, Ahmed Kamal, Hatem Beshir, Amr Moursi, Ahmed Ramadan, Sarah Hamed N. Taha · 2020 · Scientific Reports
  94. COVID-19: from epidemiology to treatment
    Juan Manuel Pericàs, Marta Hernández Meneses, Timothy Patrick Sheahan, Eduard Quintana, Juan Ambrosioni, Elena Sandoval, Carlos Falces, María Ángeles Marcos, Montserrat Tuset, Anna Vilella et al. · 2020 · European Heart Journal
  95. A comparison of COVID-19, SARS and MERS
    Tingting Hu, Ying Liu, Mingyi Zhao, Quan Zhuang, Linyong Xu, Qingnan He · 2020 · PeerJ
  96. The Challenges of Vaccine Development against a New Virus during a Pandemic
    Michael Diamond, Theodore C. Pierson · 2020 · Cell Host & Microbe
  97. Minimization of spreading of SARS-CoV-2 via household waste produced by subjects affected by COVID-19 or in quarantine
    Francesco Di Maria, Eleonora Beccaloni, Lucia Bonadonna, Carla Cini, Elisabetta Confalonieri, Giuseppina La Rosa, Maria Rosaria Milana, Emanuela Testai, Federica Scaini · 2020 · The Science of The Total Environment
  98. SARS-CoV-2 infections in children and young people
    Susanna Felsenstein, Christian Michael Hedrich · 2020 · Clinical Immunology
  99. Zoonotic origins of human coronavirus 2019 (HCoV-19 / SARS-CoV-2): why is this work important?
    Gary Wong, Yuhai Bi, Qi-Hui Wang, Xin-Wen Chen, Zhigang Zhang, Yong‐Gang Yao · 2020 · 动物学研究
  100. Live and Wet Markets: Food Access versus the Risk of Disease Emergence
    Naguib, Mahmoud M., Li, Ruiyun, Ling, Jiaxin, Grace, Delia, Nguyen-Viet, Hung, Lindahl, Johanna F. · 2021 · Trends in Microbiology